Axsome Therapeutics AXSM
NASDAQ AXSM
$184.39 -1.75 (-0.94%)
At close: Sep 30, 2026 · 4:00 PM EDT

Axsome Therapeutics (AXSM) Operating Expenses (2015 - 2026)

Updated

Axsome Therapeutics' Operating Expenses came in at $268.02 million for Q2 2026, up 43.5% from $186.76 million a year earlier and up 5.3% from the prior quarter.

Analysis

Axsome Therapeutics (AXSM) Operating Expenses (2015 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Axsome Therapeutics reported Operating Expenses of $962.64 million, up 33.0% year-over-year; for FY2025, it was $805.26 million, up 20.9% from FY2024.

  • Operating Expenses has increased in each of the last eight years, with a five-year compound annual growth rate of 52.0% (FY2020 to FY2025).
  • Going back by year, Operating Expenses was $666.26 million in FY2024 (+32.6%), $502.43 million in FY2023 (+118.6%), $229.84 million in FY2022 (+84.3%) and $124.71 million in FY2021 (+25.8%).
  • The Q2 2026 figure represents the highest quarterly Operating Expenses in data going back to Q1 2015.
  • Year-over-year, Operating Expenses has increased for 21 consecutive quarters, with growth averaging 27.9% over the last eight quarters.
  • Across the past five years, year-over-year growth in Operating Expenses ran from 12.7% in Q4 2024 to 163.7% in Q1 2023.
  • Business Quant data shows AXSM's Operating Expenses at $254.56 million (Q1 2026), $222.96 million (Q4 2025) and $217.1 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 10.12 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 10.56 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -9.70 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 18.20 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 2.09 Bn
10 Axsome Therapeutics 9.74 Bn 8.46 Bn 204.81 Mn 268.02 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 268.02 Mn
Mar 31, 2026 254.56 Mn
Dec 31, 2025 222.96 Mn
Sep 30, 2025 217.10 Mn
Jun 30, 2025 186.76 Mn
Mar 31, 2025 178.45 Mn
Dec 31, 2024 191.38 Mn
Sep 30, 2024 167.39 Mn
Jun 30, 2024 165.21 Mn
Mar 31, 2024 142.27 Mn
Dec 31, 2023 169.80 Mn
Sep 30, 2023 119.91 Mn
Jun 30, 2023 111.76 Mn
Mar 31, 2023 100.95 Mn
Dec 31, 2022 84.29 Mn
Sep 30, 2022 59.26 Mn
Jun 30, 2022 48.00 Mn
Mar 31, 2022 38.29 Mn
Dec 31, 2021 32.61 Mn
Sep 30, 2021 33.41 Mn
API Access

Axsome Therapeutics Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=AXSM&period=max&api_key=YOUR_API_KEY